SOURCE 3 Registry: Design and 30-day results of the european postapproval registry of the latest generation of the sapien 3 transcatheter heart valve

Circulation

Volumn 135, Issue 12, 2017, Pages 1123-1132

  Wendler, Olaf ^a   Schymik, Gerhard ^b   Treede, Hendrik ^c   Baumgartner, Helmut ^d   Dumonteil, Nicolas ^e   Ihlberg, Leo ^f   Neumann, Franz Josef ^g   Tarantini, Giuseppe ^h   Zamarano, José Luis ⁱ   Vahanian, Alec ^j  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Municipal Hospital   (Germany)

^c UNIVERSITY HEART CENTER HAMBURG   (Germany)

^d UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^e CLINIQUE PASTEUR   (France)

^f HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^g Heart Centre   (Germany)

^h UNIVERSITY OF PADOVA   (Italy)

ⁱ HOSPITAL RAMÓN Y CAJAL   (Spain)

^j BICHAT HOSPITAL   (France)

more..

Author keywords

Aortic valve; Aortic valve stenosis; Bioprosthesis; Cardiac surgical procedures; Heart valves

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

AGED; ANTICOAGULANT THERAPY; ARTICLE; ATRIOVENTRICULAR BLOCK; BLEEDING; CARDIOPULMONARY BYPASS; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONSCIOUS SEDATION; CONVERSION TO OPEN SURGERY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DEVICE APPROVAL; DIABETES MELLITUS; DUAL ANTIPLATELET THERAPY; FEMALE; HEART ARRHYTHMIA; HEART HEMODYNAMICS; HEART LEFT BUNDLE BRANCH BLOCK; HUMAN; KIDNEY FAILURE; KIDNEY INJURY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PACEMAKER IMPLANTATION; PERCUTANEOUS AORTIC VALVE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REGISTER; TRANSCATHETER AORTIC VALVE IMPLANTATION; VERY ELDERLY; ADVERSE EFFECTS; CLINICAL TRIAL; COMPLICATION; HEART VALVE DISEASES; HEMODYNAMICS; MORTALITY; MULTICENTER STUDY; RISK FACTOR; STROKE; TIME FACTOR; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CAUSE OF DEATH; COMORBIDITY; CORONARY ARTERY DISEASE; FEMALE; HEART VALVE DISEASES; HEMODYNAMICS; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; REGISTRIES; RISK FACTORS; STROKE; TIME FACTORS; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 85011279075     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.116.025103     Document Type: Article

References (14)

1. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-1607. doi: 10.1056/NEJMoa1008232.
2. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-2198. doi: 10.1056/NEJMoa1103510.
3. Popma JJ, Adams DH, Reardon MJ, Yakubov SJ, Kleiman NS, Heimansohn D, Hermiller J Jr, Hughes GC, Harrison JK, Coselli J, Diez J, Kafi A, Schreiber T, Gleason TG, Conte J, Buchbinder M, Deeb GM, Carabello B, Serruys PW, Chenoweth S, Oh JK; CoreValve United States Clinical Investigators. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol. 2014;63:1972-1981. doi: 10.1016/j. jacc.2014.02.556.
4. Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, Thourani VH, Tuzcu EM, Miller DC, Herrmann HC, Doshi D, Cohen DJ, Pichard AD, Kapadia S, Dewey T, Babaliaros V, Szeto WY, Williams MR, Kereiakes D, Zajarias A, Greason KL, Whisenant BK, Hodson RW, Moses JW, Trento A, Brown DL, Fearon WF, Pibarot P, Hahn RT, Jaber WA, Anderson WN, Alu MC, Webb JG; PARTNER 2 Investigators. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609-1620. doi: 10.1056/NEJMoa1514616.
5. Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H, Eggebrecht H, Rubino P, Michev I, Lange R, Anderson WN, Wendler O. Thirty-day results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010;122:62-69. doi: 10.1161/CIRCULATIONAHA. 109.907402.
6. Webb J, Gerosa G, Lefèvre T, Leipsic J, Spence M, Thomas M, Thielmann M, Treede H, Wendler O, Walther T. Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve. J Am Coll Cardiol. 2014;64:2235-2243. doi: 10.1016/j. jacc.2014.09.026.
7. Vahanian A, Urena M, Walther T, Treede H, Wendler O, Lefèvre T, Spence MS, Redwood S, Kahlert P, Rodes-Cabau J, Leipsic J, Webb J. Thirty-day outcomes in patients at intermediate risk for surgery from the SAPIEN 3 European approval trial. EuroIntervention. 2016;12:e235-e243. doi: 10.4244/EIJV12I2A37.
8. Kodali S, Thourani VH, White J, Malaisrie SC, Lim S, Greason KL, Williams M, Guerrero M, Eisenhauer AC, Kapadia S, Kereiakes DJ, Herrmann HC, Babaliaros V, Szeto WY, Hahn RT, Pibarot P, Weissman NJ, Leipsic J, Blanke P, Whisenant BK, Suri RM, Makkar RR, Ayele GM, Svensson LG, Webb JG, Mack MJ, Smith CR, Leon MB. Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. Eur Heart J. 2016;37:2252-2262. doi: 10.1093/eurheartj/ehw112.
9. Thourani VH, Kodali S, Makkar RR, Herrmann HC, Williams M, Babaliaros V, Smalling R, Lim S, Malaisrie SC, Kapadia S, Szeto WY, Greason KL, Kereiakes D, Ailawadi G, Whisenant BK, Devireddy C, Leipsic J, Hahn RT, Pibarot P, Weissman NJ, Jaber WA, Cohen DJ, Suri R, Tuzcu EM, Svensson LG, Webb JG, Moses JW, Mack MJ, Miller DC, Smith CR, Alu MC, Parvataneni R, D'Agostino RB Jr, Leon MB. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016;387:2218-2225. doi: 10.1016/S0140-6736(16)30073-3.
10. Smith LA, Dworakowski R, Bhan A, Delithanasis I, Hancock J, Maccarthy PA, Wendler O, Thomas MR, Monaghan MJ. Real-time threedimensional transesophageal echocardiography adds value to transcatheter aortic valve implantation. J Am Soc Echocardiogr. 2013;26:359-369. doi: 10.1016/j.echo.2013.01.014.
11. Yang TH, Webb JG, Blanke P, Dvir D, Hansson NC, Nrgaard BL, Thompson CR, Thomas M, Wendler O, Vahanian A, Himbert D, Kodali SK, Hahn RT, Thourani VH, Schymik G, Precious B, Berger A, Wood DA, Pibarot P, Rodés-Cabau J, Jaber WA, Leon MB, Walther T, Leipsic J. Incidence and severity of paravalvular aortic regurgitation with multidetector computed tomography nominal area oversizing or undersizing after transcatheter heart valve replacement with the Sapien 3: a comparison with the Sapien XT. JACC Interv. 2015;8:462-471. doi: 10.1016/j. jcin.2014.10.014.
12. Schymik G, Lefèvre T, Bartorelli AL, Rubino P, Treede H, Walther T, Baumgartner H, Windecker S, Wendler O, Urban P, Mandinov L, Thomas M, Vahanian A. European experience with the secondgeneration Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry. JACC Cardiovasc Interv. 2015;8:657-669. doi: 10.1016/j.jcin.2014.10.026.
13. Nijhoff F, Abawi M, Agostoni P, Ramjankhan FZ, Doevendans PA, Stella PR. Transcatheter aortic valve implantation with the new balloon-expandable Sapien 3 versus Sapien XT valve system: a propensity score-matched single-center comparison [published online ahead of print June 8, 2015]. Circ Cardiovasc Interv. doi: 10.1161/CIRCINTERVENTIONS.115.002408.
14. Arai T, Lefèvre T, Hovasse T, Morice MC, Garot P, Benamer H, Unterseeh T, Hayashida K, Watanabe Y, Bouvier E, Cormier B, Chevalier B. Comparison of Edwards SAPIEN 3 versus SAPIEN XT in transfemoral transcatheter aortic valve implantation: Difference of valve selection in the real world. J Cardiol. 2017;69:565-569.